Cargando…

Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment

BACKGROUND: Tuberculosis (TB) and chronic Hepatitis B virus (HBV) infection are common in China. Fist-line anti-TB medications often produce drug-induced liver injury (DILI). This study sought to investigate whether TB patients with chronic HBV co-infection are more susceptible to liver failure and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Lubiao, Bao, Dujing, Gu, Lin, Gu, Yurong, Zhou, Liang, Gao, Zhiliang, Huang, Yuehua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029116/ https://www.ncbi.nlm.nih.gov/pubmed/29970037 http://dx.doi.org/10.1186/s12879-018-3192-8

Ejemplares similares

Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment
por: Li, Xiaoyan, et al.
Publicado: (2017)

Correlations between cytokines produced by T cells and clinical-virological characteristics in untreated chronic hepatitis B patients
por: Gu, Yurong, et al.
Publicado: (2019)

Dynamic Changes of Lipopolysaccharide Levels in Different Phases of Acute on Chronic Hepatitis B Liver Failure
por: Pan, Calvin, et al.
Publicado: (2012)

Co-infection With Hepatitis B in Tuberculosis Patients on Anti-tuberculosis Treatment and the Final Outcome
por: Khan, Amir F, et al.
Publicado: (2021)

Serum HBV pregenomic RNA is correlated with Th1/Th2 immunity in treatment‐naïve chronic hepatitis B patients
por: Gu, Yurong, et al.
Publicado: (2019)

Soluble programmed death‐1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B
por: Zhou, Liang, et al.
Publicado: (2019)

GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis
por: Wu, Xiaojuan, et al.
Publicado: (2017)

Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B
por: Gu, Yurong, et al.
Publicado: (2020)

An Immuno-Clinic score model for evaluating T cell immunity and predicting early antiviral therapy effectiveness in chronic hepatitis B
por: Gu, Yurong, et al.
Publicado: (2020)

HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression
por: Chen, Lubiao, et al.
Publicado: (2016)

A Practical Model Evaluating Antiviral Cytokines by Natural Killer Cells in Treatment Naïve Patients with Chronic Hepatitis B Virus Infection
por: Li, Xiaoyan, et al.
Publicado: (2017)

Hepatitis C Virus Co-Infection Increases the Risk of Anti-Tuberculosis Drug-Induced Hepatotoxicity among Patients with Pulmonary Tuberculosis
por: Lomtadze, Nino, et al.
Publicado: (2013)

The Defect in Autophagy Induction by Clinical Isolates of Mycobacterium Tuberculosis Is Correlated with Poor Tuberculosis Outcomes
por: Li, Furong, et al.
Publicado: (2016)

Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury
por: Kim, Wan Soo, et al.
Publicado: (2016)

A novel T-cell epitope in the transmembrane region of the hepatitis B virus envelope protein responds upon dendritic cell expansion
por: Chen, Lubiao, et al.
Publicado: (2018)

Tuberculosis Screening before Anti–Hepatitis C Virus Therapy in Prisons
por: Babudieri, Sergio, et al.
Publicado: (2012)

CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma
por: Gu, Yurong, et al.
Publicado: (2020)

Determinants of Poor Adherence to Anti-Tuberculosis Treatment in Mumbai, India
por: Bagchi, Suparna, et al.
Publicado: (2010)

Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis
por: Kempker, Russell R., et al.
Publicado: (2015)

Impacts of hepatitis B and hepatitis C co-infection with tuberculosis, a prospective cohort study
por: Feleke, Berhanu Elfu, et al.
Publicado: (2020)

The mutational signatures of poor treatment outcomes on the drug-susceptible Mycobacterium tuberculosis genome
por: Chen, Yiwang, et al.
Publicado: (2023)

Poor tuberculosis treatment outcomes in Southern Mozambique (2011–2012)
por: García-Basteiro, Alberto L., et al.
Publicado: (2016)

Poor in vitro fertilisation outcomes in genital tuberculosis – Case report
por: Tjahyadi, Dian, et al.
Publicado: (2022)

Spinal Tuberculosis: Features and Early Predictive Factors of Poor Outcomes
por: Boussaid, Soumaya, et al.
Publicado: (2023)

Serum HBV pregenomic RNA exhibited opposite associations with NK(dim) and NK(bright) cell immunity in treatment-naïve chronic hepatitis B patients
por: Gu, Yurong, et al.
Publicado: (2021)

A systematic review of hepatic tuberculosis with considerations in human immunodeficiency virus co-infection
por: Hickey, Andrew J, et al.
Publicado: (2015)

Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus
por: Ichikawa, Chikako, et al.
Publicado: (2021)

Erratum to: Poor tuberculosis treatment outcomes in Southern Mozambique (2011-2012)
por: García-Basteiro, Alberto L., et al.
Publicado: (2016)

Poor outcomes in recurrent tuberculosis: More than just drug resistance?
por: Cohen, Danielle B., et al.
Publicado: (2019)

Case report: Hepatic tuberculosis mimicking hepatocellular carcinoma in a patient with cirrhosis induced by hepatitis B virus
por: Hu, Na, et al.
Publicado: (2022)

ADVERSE EVENTS TO FIRST LINE ANTI-TUBERCULOSIS DRUGS IN PATIENTS CO-INFECTED WITH HIV AND TUBERCULOSIS
por: Michael, O.S., et al.
Publicado: (2016)

Deregulated lncRNAs in B Cells from Patients with Active Tuberculosis
por: Fu, Yurong, et al.
Publicado: (2017)

Expression and clinical significance of inhibitory receptor Leukocyte-associated immunoglobulin-like receptor-1 on peripheral blood T cells of chronic hepatitis B patients: A cross-sectional study
por: Gu, Yurong, et al.
Publicado: (2021)

Anti-tuberculosis drug-induced liver injury in patient with hepatitis B and cirrhosis: A case report
por: Aminy, Rusdi Zakki, et al.
Publicado: (2022)

Time to poor treatment outcome and its predictors among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara region, Ethiopia: retrospective cohort study
por: Ketema, Daniel Bekele, et al.
Publicado: (2019)

Anti-Tuberculosis Work
Publicado: (1943)

The Anti-Tuberculosis Campaign
Publicado: (1920)

Anti-Tuberculosis Agitation
Publicado: (1907)

Poor Penetration of Antibiotics Into Pericardium in Pericardial Tuberculosis
por: Shenje, Justin, et al.
Publicado: (2015)

Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosis
por: Ye, Mei-Feng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qa6for7a9pm2bo006sglva479p